212 related articles for article (PubMed ID: 29752261)
1. NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines.
Huergo-Zapico L; Parodi M; Cantoni C; Lavarello C; Fernández-Martínez JL; Petretto A; DeAndrés-Galiana EJ; Balsamo M; López-Soto A; Pietra G; Bugatti M; Munari E; Marconi M; Mingari MC; Vermi W; Moretta L; González S; Vitale M
Cancer Res; 2018 Jul; 78(14):3913-3925. PubMed ID: 29752261
[TBL] [Abstract][Full Text] [Related]
2. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation.
Vacca P; Martini S; Garelli V; Passalacqua G; Moretta L; Mingari MC
Eur J Immunol; 2013 Feb; 43(2):550-61. PubMed ID: 23192659
[TBL] [Abstract][Full Text] [Related]
3. Shifting the Balance of Activating and Inhibitory Natural Killer Receptor Ligands on
Frazao A; Colombo M; Fourmentraux-Neves E; Messaoudene M; Rusakiewicz S; Zitvogel L; Vivier E; Vély F; Faure F; Dréno B; Benlalam H; Bouquet F; Savina A; Pasmant E; Toubert A; Avril MF; Caignard A
Cancer Immunol Res; 2017 Jul; 5(7):582-593. PubMed ID: 28576831
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
5. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.
Boerman GH; van Ostaijen-ten Dam MM; Kraal KC; Santos SJ; Ball LM; Lankester AC; Schilham MW; Egeler RM; van Tol MJ
Cancer Immunol Immunother; 2015 May; 64(5):573-83. PubMed ID: 25854581
[TBL] [Abstract][Full Text] [Related]
6. Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.
Balsamo M; Vermi W; Parodi M; Pietra G; Manzini C; Queirolo P; Lonardi S; Augugliaro R; Moretta A; Facchetti F; Moretta L; Mingari MC; Vitale M
Eur J Immunol; 2012 Jul; 42(7):1833-42. PubMed ID: 22585684
[TBL] [Abstract][Full Text] [Related]
7. Implication of Highly Cytotoxic Natural Killer Cells for Esophageal Squamous Cell Carcinoma Treatment.
Lim KS; Mimura K; Kua LF; Shiraishi K; Kono K
J Immunother; 2018; 41(6):261-273. PubMed ID: 29683892
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
[TBL] [Abstract][Full Text] [Related]
9. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
[TBL] [Abstract][Full Text] [Related]
10. NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
Cantoni C; Huergo-Zapico L; Parodi M; Pedrazzi M; Mingari MC; Moretta A; Sparatore B; Gonzalez S; Olive D; Bottino C; Castriconi R; Vitale M
J Immunol Res; 2016; 2016():4684268. PubMed ID: 27294158
[TBL] [Abstract][Full Text] [Related]
11. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients.
Konjević G; Mirjačić Martinović K; Vuletić A; Babović N
Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360
[TBL] [Abstract][Full Text] [Related]
12. MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions.
Campbell AR; Duggan MC; Suarez-Kelly LP; Bhave N; Opheim KS; McMichael EL; Trikha P; Parihar R; Luedke E; Lewis A; Yung B; Lee R; Raulet D; Tridandapani S; Groh V; Yu L; Yildiz V; Byrd JC; Caligiuri MA; Carson WE
Cancer Immunol Res; 2017 Sep; 5(9):778-789. PubMed ID: 28724544
[TBL] [Abstract][Full Text] [Related]
13. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor.
Vitale M; Della Chiesa M; Carlomagno S; Pende D; Aricò M; Moretta L; Moretta A
Blood; 2005 Jul; 106(2):566-71. PubMed ID: 15784725
[TBL] [Abstract][Full Text] [Related]
14. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.
Pietra G; Manzini C; Rivara S; Vitale M; Cantoni C; Petretto A; Balsamo M; Conte R; Benelli R; Minghelli S; Solari N; Gualco M; Queirolo P; Moretta L; Mingari MC
Cancer Res; 2012 Mar; 72(6):1407-15. PubMed ID: 22258454
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells.
Ricciardi M; Zanotto M; Malpeli G; Bassi G; Perbellini O; Chilosi M; Bifari F; Krampera M
Br J Cancer; 2015 Mar; 112(6):1067-75. PubMed ID: 25668006
[TBL] [Abstract][Full Text] [Related]
16. Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.
Belting L; Hömberg N; Przewoznik M; Brenner C; Riedel T; Flatley A; Polić B; Busch DH; Röcken M; Mocikat R
Eur J Immunol; 2015 Sep; 45(9):2593-601. PubMed ID: 26151313
[TBL] [Abstract][Full Text] [Related]
17. [Effect of Epithelial-to-mesenchymal Transition on Biological Activity of NK Cells in Esophageal Squamous Cell Carcinoma].
Gao FX; Wu J; Ren DL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jan; 50(1):40-47. PubMed ID: 31037903
[TBL] [Abstract][Full Text] [Related]
18. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.
Kloss M; Decker P; Baltz KM; Baessler T; Jung G; Rammensee HG; Steinle A; Krusch M; Salih HR
J Immunol; 2008 Nov; 181(10):6711-9. PubMed ID: 18981088
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines.
Konjevic G; Vuletic A; Mirjacic Martinovic K; Krivokuca A; Jankovic R; Babovic N
J Membr Biol; 2017 Oct; 250(5):507-516. PubMed ID: 28887642
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3
Lee SH; Shin DJ; Kim Y; Kim CJ; Lee JJ; Yoon MS; Uong TNT; Yu D; Jung JY; Cho D; Jung BG; Kim SK; Suh GH
Front Immunol; 2018; 9():841. PubMed ID: 29755462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
